Translate this page into:
Sinus Histiocytosis with Massive Lymphadenopathy and Unusual Multi-organ Spread: A Case of Rosai–Dorfman Disease
*Corresponding author: Dr. Manish Ora, Department of Nuclear Medicine, SGPGIMS, Lucknow - 226 014, Uttar Pradesh, India. drmanishora@yahoo.com
-
Received: ,
Accepted: ,
How to cite this article: Bana A, Sharma S, Ora M, Pradhan PK. Sinus Histiocytosis with Massive Lymphadenopathy and Unusual Multi-Organ Spread: A Case of Rosai–Dorfman Disease. Indian J Nucl Med 2026;41:247-49. doi: 10.25259/IJNM_139_25
Abstract
Rosai-Dorfman disease (RDD) is a rare but distinctive clinicopathologic entity of unknown etiology affecting lymph nodes as well as extranodal sites. It was originally described as sinus histiocytosis with massive lymphadenopathy.It is a rare histiocytic proliferative disorder with a distinctive microscopic appearance. A 64 year old female presented with multiple swellings in the neck region. Biopsy from left cervical lymph node favors the finding of Rosai dorfmann disease. CECT of head and neck revealed polypoidal heterogeneously enhancing intracranial lesions in the posterior fossa around right CP angle with multiple enlarged lymph nodal mass at cervical and bilateral parotid stations .Another lesion was seen superficial to sternocleidomastoid muscle and in right orbit. MRI head revealed multiple polypoidal homogeneously enhancing soft tissue lesion in both cerebellar hemispheres and right CP angle. Similar lesions were also seen in right infra orbital space along right lacrimal gland and in left infra orbital space. 18F-FDG PET/CT demonstrated metabolically active lesions involving the bilateral orbits, cervical lymph nodes, right nasopharynx, tail of pancreas, bilateral renal cortices, frontal bone, right acetabulum, right paravertebral muscles, and multiple subcutaneous sites (breast, arm, lumbar region). The patient was started on dexamethasone and methotrexate.
Keywords
Chemotherapy
Rosai–dorfman
Sinus histiocytosin
CASE PRESENTATION
A 64-year-old female presented with gradually progressive wellings in the neck region since 2021. She had swelling in the right orbital for 1 month. The patient complained of a progressively increasing headache for 1 month. On clinical examination, she had multiple discrete swellings on both sides of the neck. Magnetic resonance imaging (MRI) head revealed multiple homogenous soft tissue lesions in the cerebellar hemispheres, causing effacement of the 4th ventricle. Similar lesions were noted in the right cerebellopontine angle and infraorbital space. Fine needle aspiration cytology of the right submandibular region suggested inflammatory pathology. Patient underwent left cervical lymph node biopsy. Histopathology was suggestive of Rosai–Dorfmann disease. On immunohistochemistry, histiocytes showed positivity for CD68 and S100 and were negative for CD1a. Laboratory investigations were unremarkable apart for anemia (haemoglobin – 9.2 g/dL). 18F- fludeoxyglucose positron emission tomography/computed tomography [Fig. 1a-f] demonstrated metabolically active lesions involving the bilateral orbits, lymph nodes, and subcutaneous (breast, arm, and lumbar region). Apart from that, the patient had lesions in the nasopharynx, pancreas, renal cortices, bones (frontal and right acetabulum), and paravertebral muscles [Fig. 2a-h].


The patient was started on dexamethasone and methotrexate.
Rosai–Dorfman disease (RDD), also known as sinus histiocytosis, is a rare non-Langerhans cell histiocytosis characterised by the accumulation of distinctive histiocytes within lymph nodes or extranodal tissues.[1]
RDD is defined by the presence of large S100-positive, CD68-positive, and CD1a-negative histiocytes exhibiting emperipolesis (engulfment of intact lymphocytes or other blood cells).[2]
It typically presents with massive, painless, bilateral cervical lymphadenopathy, often affecting children and young adults, but extranodal involvement (such as skin, soft tissues, or other organs) is common and sometimes predominant.[3]
Laboratory evaluation may reveal normocytic and normochromic anemia, leukocytosis, thrombocytopenia, eosinophilia, hypergammaglobulinemia, and an elevated ESR. Intermittent fever, night sweats, weight loss, and asthenia may be present.[2]
The most common presenting feature was subcutaneous nodules, with lymph node involvement. Skeletal and head and neck involvement are less common (11%–25%).[3]
Multi-organ involvement is rare. Nasal cavity and paranasal sinuses (16%); eye, orbit, and ocular adnexa (11%); bone (11%); salivary gland (7%); central nervous system (7%) are less commonly involved. While diseases involving the oral cavity (4%), kidney and genitourinary tract (3%), respiratory tract (3%), liver (1%), tonsils (1%), breast (<1%), and pancreas are rare.[4-6]
Patients with multifocal and extranodal RDD seem to have an unfavourable prognosis. Intensive systemic chemotherapy and targeted therapies may be justified.[7]
Author contributions:
AB: Data acquisition, literature search, and drafting of the manuscript; SS: Data interpretation, and drafting of the manuscript; MO: Conceptualisation, overall supervision, manuscript editing, and coordination of the research work; PKP: critical review of the manuscript, and final approval of the manuscript. All authors read and approved the final manuscript.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for their images and other clinical information to be reported in the journal. The patient understand that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Rosai-Dorfman disease: An overview. J Clin Pathol. 2020;73:697-705.
- [CrossRef] [PubMed] [Google Scholar]
- Case study: Rosai-Dorfman disease and its multifaceted aspects. J Blood Med. 2024;15:123-8.
- [CrossRef] [PubMed] [Google Scholar]
- Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica. 2020;105:348-57.
- [CrossRef] [PubMed] [Google Scholar]
- Imaging manifestations of hematologic diseases with renal and perinephric involvement. Radiographics. 2016;36:1038-54.
- [CrossRef] [PubMed] [Google Scholar]
- Extranodal Rosai-Dorfman disease-a review of diagnostic testing and management. J Community Hosp Intern Med Perspect. 2022;12:18-22.
- [CrossRef] [PubMed] [Google Scholar]
- Rosai-Dorfman disease of the pancreas shows significant histologic overlap with IgG4-related disease. Am J Surg Pathol. 2019;43:1536-46.
- [CrossRef] [PubMed] [Google Scholar]
- Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-destombes disease. Blood. 2018;131:2877-90.
- [CrossRef] [PubMed] [Google Scholar]
